Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN113278007B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113278007B details a copper-catalyzed route for 2-hydroxy-indol-3-ones, offering high yields and mild conditions for pharmaceutical intermediate manufacturing.